Used for: Tumors from von Hippel-Lindau (VHL) disease · Kidney cancer with a clear cell component (ccRCC) · Pheochromocytoma or paraganglioma (PPGL) · 2 more
How to pay the least
Ask for the cash price
Welireg
We didn’t find one.
What to do
Ask your pharmacy for Welireg’s cash price, and one or two other pharmacies too.
Welireg’s savings card works only with insurance from a job or one you bought.
Other ways
Free from the maker, if you qualify Merck Patient Assistance Program. You may qualify for the program if you have a household income of $63,840 or less for individuals, $86,560 or less for couples, or $132,000 or less for a family of 4. Or call 800-727-5400.
“Eligible, privately insured patients may pay as little as $5 per prescription on each qualifying prescription.”
From the maker’s offer on activatethecard.com, checked November 17, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Maker’s card or discount card?
A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.
WELIREG is a hypoxia-inducible factor inhibitor indicated:
von Hippel-Lindau disease
for treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), not requiring immediate surgery.
Renal Cell Carcinoma with a Clear Cell Component
in combination with pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph, for the adjuvant treatment of adult patients with renal cell carcinoma with a clear cell component (ccRCC) at intermediate-high or high risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions.
in combination with lenvatinib for the treatment of adult patients with advanced ccRCC following a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor.
as monotherapy, for treatment of adult patients with advanced ccRCC following a PD-1 or PD-L1 inhibitor and a vascular endothelial growth factor tyrosine kinase inhibitor (VEGF-TKI).
Pheochromocytoma or Paraganglioma
for treatment of adult and pediatric patients 12 years and older with locally advanced, unresectable, or metastatic pheochromocytoma or paraganglioma (PPGL).
Source: the FDA label for Welireg (Merck Sharp & Dohme LLC), September 24, 2026. Full label on DailyMed
Good to know
“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.
Prices checked November 17, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/welireg/